As a Free StocksGuide user, you can view scores for all 7,048 stocks worldwide.
11 Analysts have issued a Adagene Inc - ADR forecast:
11 Analysts have issued a Adagene Inc - ADR forecast:
| Jun '25 |
+/-
%
|
||
| Revenue | 0.10 0.10 |
88%
88%
|
|
| Gross Profit | - - |
-
|
|
| EBITDA | -33 -33 |
10%
10%
|
|
| EBIT (Operating Income) EBIT | -33 -33 |
10%
10%
|
|
| Net Profit | -30 -30 |
6%
6%
|
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Adagene, Inc. engages in the discovery and development of novel antibody-based cancer immunotherapies. Its dynamic precision library platform is composed of the following proprietary technologies: NEObody, SAFEbody, and POWERbody. The company was founded by Ge Li and Pei Zhi Luo on February 25, 2011 and is headquartered in Suzhou, China.
| Head office | Cayman Islands |
| CEO | Peizhi Luo |
| Employees | 138 |
| Founded | 2011 |
| Website | www.adagene.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.


